These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20410817)

  • 1. Purified vs. nonpurified venom immunotherapy.
    Bilò MB; Antonicelli L; Bonifazi F
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):330-6. PubMed ID: 20410817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The VISYT trial: Venom Immunotherapy Safety and Tolerability with purified vs nonpurified extracts.
    Bilò MB; Severino M; Cilia M; Pio A; Casino G; Ferrarini E; Campodonico P; Milani M
    Ann Allergy Asthma Immunol; 2009 Jul; 103(1):57-61. PubMed ID: 19663128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations.
    Ruëff F; Wolf H; Schnitker J; Ring J; Przybilla B
    Allergy; 2004 Jun; 59(6):589-95. PubMed ID: 15147443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
    Goldberg A; Yogev A; Confino-Cohen R
    Int Arch Allergy Immunol; 2011; 156(1):90-8. PubMed ID: 21447964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse reactions to venom immunotherapy.
    Ramirez DA; Londono S; Evans R
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of venom immunotherapy.
    Hafner T; DuBuske L; Kosnik M
    Ann Allergy Asthma Immunol; 2008 Feb; 100(2):162-5. PubMed ID: 18320918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venom immunotherapy for preventing allergic reactions to insect stings.
    Boyle RJ; Elremeli M; Hockenhull J; Cherry MG; Bulsara MK; Daniels M; Oude Elberink JN
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008838. PubMed ID: 23076950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome after venom immunotherapy.
    Golden DB
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):337-41. PubMed ID: 20610978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
    Goldberg A; Confino-Cohen R
    J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexible approaches in the design of subcutaneous immunotherapy protocols for Hymenoptera venom allergy.
    Alessandrini AE; Berra D; Rizzini FL; Mauro M; Melchiorre A; Rossi F; Spezia D; Stanizzi R; Ricciardi L; Burastero SE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):92-7. PubMed ID: 16892788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of hyposensitization with bee and wasp venom].
    Adolph J; Dehnert I; Fischer JF; Wenz W
    Z Erkr Atmungsorgane; 1986; 166(1):119-24. PubMed ID: 3953108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hymenoptera venom immunotherapy: Safety and efficacy of an accelerated induction regimen with depot aluminum adsorbed extracts.
    Brunetto S; Gammeri L; Buta F; Gangemi S; Ricciardi L
    Allergy Asthma Proc; 2024 May; 45(3):195-200. PubMed ID: 38755779
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety of Ultrarush Venom Immunotherapy: Comparison Between Children and Adults.
    Nittner-Marszalska M; Cichocka-Jarosz E; Małaczyńska T; Kraluk B; Rosiek-Biegus M; Kosinska M; Pawłowicz R; Lis G
    J Investig Allergol Clin Immunol; 2016; 26(1):40-7. PubMed ID: 27012015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and efficacy of immunotherapy with aluminum hydroxide-adsorbed venom extract of Vespula spp. An open, retrospective study.
    Poli F; Longo G; Parmiani S
    Allergol Immunopathol (Madr); 2001; 29(5):191-6. PubMed ID: 11720652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rush venom immunotherapy in patients experiencing recurrent systemic reactions to conventional venom immunotherapy.
    Goldberg A; Confino-Cohen R
    Ann Allergy Asthma Immunol; 2003 Oct; 91(4):405-10. PubMed ID: 14582821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of allergy to hymenoptera venoms.
    Hamilton RG
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):323-9. PubMed ID: 20543672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract.
    Roumana A; Pitsios C; Vartholomaios S; Kompoti E; Kontou-Fili K
    J Allergy Clin Immunol; 2009 Aug; 124(2):379-81. PubMed ID: 19560804
    [No Abstract]   [Full Text] [Related]  

  • 19. A controlled trial of immunotherapy in insect hypersensitivity.
    Hunt KJ; Valentine MD; Sobotka AK; Benton AW; Amodio FJ; Lichtenstein LM
    N Engl J Med; 1978 Jul; 299(4):157-61. PubMed ID: 78446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rush hyposensitization with Hymenoptera venoms. Tolerance and results of therapy].
    Przybilla B; Ring J; Griesshammer B; Braun-Falco O
    Dtsch Med Wochenschr; 1987 Mar; 112(11):416-24. PubMed ID: 3816590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.